Thursday May 23, 2019 Change -3.04% Price $4.79
Chart period: 2019-02-25 - 2019-05-23




Will OCX stock price go up or down on Tue, 28 May 2019?


OncoCyte Corp Forecast and Stock Analysis

Technical OCX stock analysis for Thursday May 23, 2019.

Buy candidate since 2019-05-20 Loss -7.17%
Shorts 2.55% ( 2019-04-15 )
Insider % n/a
Institutional % 23.70%
Beta 0.74
ROA -55.33%
Price to book USD 6.72
P/E Ratio -12.20
Next Earnings Date 2019-08-12

OncoCyte Corp fell by -3.04% in the last day ( Thursday, 23rd May 2019 ) from $4.94 to $4.79 and has now fallen 5 days in a row. During day the stock fluctuated 9.67% from a day low at $4.47 to a day high of $4.90. The price has been going up and down for this period, and there has been a 15.14% gain for the last 2 weeks. Volume has increased in the last day by 63 492 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 194 654 shares bought and sold for approximately $932 393.00.

Quick summary:

  • 30 day high of the OCX stock price was $5.60 and low was $3.85.
  • 90 day high was $5.60 and low was $3.20.
  • 52 week high for the OncoCyte Corp - $6.92 and low - $1.17.


OncoCyte Corp lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 40.33% during the next 3 months and, with 90% probability hold a price between $6.20 and $7.79 at the end of this period.

Click here for today's Top 5 Trending Companies


There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Friday May 17, 2019, which indicates further falls until a new bottom pivot has been found. OncoCyte Corp gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". OncoCyte Corp holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $5.07. On a fall, the stock will find some support from the long-term average at approximately $4.44. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 58 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $4.25 and $4.15.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, OncoCyte Corp finds support just below today's level at $4.25. If this is broken, then the next support from accumulated volume will be at $4.15 and $3.94.

Support: $4.25 Price: $4.79 Resistance: $5.04


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.43 between high and low, or 9.67%. For the last week, the stock has had a daily average volatility of 8.94%.

Our recommended stoploss: $4.51 (-5.89%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 4 days ago.)

8.94 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

OCX $4.79 ($-0.15 -3.04%)
OCX is down $0.15 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for OCX based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for readers.

Click here – the OCX analysis is free »

Will OCX stock price go up or down
on Tue, 28 May 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank